Nuvaring

   
Google
 
Web NewDrugInformation.com

Nuvaring


Drug - Nuvaring
The trade name of the product as shown on the labeling.

Dosage - RING; VAGINAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ethinyl Estradiol; Etonogestrel
Multiple ingredients are in alphabetical order.

Strength - 0.015MG;0.12MG
The potency of the active ingredient(s), Ethinyl Estradiol; Etonogestrel. May repeat for multiple part products.

Applicant - ORGANON USA INC
The firm name holding legal responsibility for Nuvaring. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021187
The FDA assigned number to Nuvaring. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Nuvaring. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 3, 2001
The date Nuvaring was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Nuvaring. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Nuvaring is in. Format is RX, OTC, DISCN.

Applicant Full Name - Organon Usa Inc
The full name of the firm holding legal responsibility for the new application of Nuvaring.

Nuvaring